PHARMACOLOGICAL ISSUES IN THE TREATMENT OF BIPOLAR DISORDER - FOCUS ON MOOD-STABILIZING COMPOUNDS

被引：0
|
作者：
POTTER, WZ [1 ]
KETTER, TA [1 ]
机构：
[1] NIMH,W CLIN RES UNIT 3,BETHESDA,MD 20892
来源：
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 1993年 / 38卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
The acute and chronic pharmacotherapy of bipolar disorder requires an understanding of the pharmacology of very dissimilar compounds - the mood stabilizers (lithium, carbamazepine and valproate) and several classes of antidepressants. No definitive data are available on the primary mode of action of mood stabilizers, and those used show no single pharmacological property. On the other hand, the pharmacokinetics and dynamics of these compounds are well studied.
引用
收藏
页码：S51 / S56
页数：6
相关论文
共 50 条
  • [41] Pharmacological treatment of bipolar disorder in children and adolescents
    Bailly, D.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (03): : 254 - 258
  • [42] Augmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability
    Martinotti, G.
    Montemitro, C.
    Pettorruso, M.
    Viceconte, D.
    Alessi, M. C.
    Di Carlo, F.
    Lucidi, L.
    Picutti, E.
    Santacroce, R.
    Di Giannantonio, M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (13) : 1575 - 1588
  • [43] Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder
    Andrew Naglich
    Bryon Adinoff
    E. Sherwood Brown
    CNS Drugs, 2017, 31 : 665 - 674
  • [44] Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder
    Naglich, Andrew
    Adinoff, Bryon
    Brown, E. Sherwood
    CNS DRUGS, 2017, 31 (08) : 665 - 674
  • [45] Pharmacological treatment for schizoaffective disorder: A comparison with schizophrenia and bipolar disorder
    Assion, H. -J.
    Schweppe, A.
    Reinbold, H.
    Frommberger, U.
    NERVENARZT, 2019, 90 : S1 - S8
  • [46] Mood stabilizers in the treatment of bipolar disorder mixed states
    Rosso, Gianluca
    Bertetto, Niccolo
    Coppola, Isabella
    Maina, Giuseppe
    RIVISTA DI PSICHIATRIA, 2012, 47 (04) : 281 - 293
  • [47] Mood stabilizers in treatment of the depressive facets of bipolar disorder
    Bourin, MS
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 95S - 95S
  • [48] Effectiveness of mood stabilizers in prophylactic treatment of bipolar disorder
    Khattech, D.
    Aissa, A.
    Ouali, U.
    Zgueb, Y.
    Jomli, R.
    EUROPEAN PSYCHIATRY, 2023, 66 : S695 - S696
  • [49] Effectiveness of mood stabilizers in prophylactic treatment of bipolar disorder
    Khattech, D.
    Aissa, A.
    Ouali, U.
    Zgueb, Y.
    Jomli, R.
    EUROPEAN PSYCHIATRY, 2023, 66 : S695 - S696
  • [50] Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response
    Kuperberg, Maya
    Kohler-Forsberg, Ole
    Shannon, Alec P.
    George, Nevita
    Greenebaum, Sophie
    Bowden, Charles L.
    Calabrese, Joseph R.
    Thase, Michael
    Shelton, Richard C.
    McInnis, Melvin
    Deckersbach, Thilo
    Tohen, Mauricio
    Kocsis, James H.
    Ketter, Terence A.
    Friedman, Edward S.
    Iosifescu, Dan, V
    Ostacher, Michael J.
    Sylvia, Louisa G.
    McElroy, Susan L.
    Nierenberg, Andrew A.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 300 : 41 - 49
12345